Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Stephan Henschen
Sign up to set email alerts
60
Publications
306
Citation Statements Received
614
Citation Statements Given
How they've been cited
557
27
276
3
How they cite others
522
9
602
3
Affiliations
Helios Hospital Schwerin
,
Johanniter-Krankenhaus Bonn
Publications
Order By: Most citations
Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
Ataseven
1
,
De Laurentiis
2
,
Azim
3
et al.
2017
European Journal of Cancer
49
11
51
0
Get access via publisher
Add to collection
Cite
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial
Witzel
1
,
Loibl
2
,
von Minckwitz
3
et al.
2010
Breast Cancer Res Treat
Abstract
Show
53
8
39
3
Get access via publisher
Add to collection
Cite
Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer—results from the GeparQuattro study (GBG 40)
von Minckwitz
1
,
Darb‐Esfahani
2
,
Loibl
3
et al.
2011
Breast Cancer Res Treat
Abstract
Show
59
5
42
0
Get access via publisher
Add to collection
Cite
Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients
Nabieva
1
,
Kellner
2
,
Fehm
3
et al.
2018
Annals of Oncology
Abstract
Show
47
0
32
0
Get access via publisher
Add to collection
Cite
A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2− Primary Breast Cancer
Robertson
1
,
Evans
2
,
Henschen
3
et al.
2020
Abstract
Show
51
0
31
0
Get access via publisher
Add to collection
Cite
Clinical and Anatomical Contributions on Brain Pathology
Henschen
1
1925
Arch NeurPsych
79
0
21
0
Get access via publisher
Add to collection
Cite
Orthotopic liver transplantation for complicated HELLP Syndrome
Strate
1
,
Broering
2
,
Bloechle
3
et al.
2000
Archives of Gynecology and Obstetrics
Abstract
Show
32
0
11
0
Get access via publisher
Add to collection
Cite
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
Matikas
1
,
Andersson
2
,
Untch
3
et al.
2024
JCO
Abstract
Show
12
2
10
0
Get access via publisher
Add to collection
Cite
1
2
3
4
5
6